植物性天然化合物作为抗结核的新疗法:重点是黄素
Shivani Pralhad Amingad1, Sushruta S Hakkimane1
1Department of Biotechnology, Manipal Institute of Technology Bengaluru, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Microbial pathogenesis
|June 5, 2025
概括
由于耐药性,迫切需要新的抗结核化合物. 这项研究审查了植物性天然产品,重点是黄素,针对潜在的新型结核病 (TB) 治疗方法.
科学领域:
- 自然产品化学 自然产品化学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由Mycobacterium tuberculosis引起的结核病 (TB) 是全球主要的健康威胁.
- 现有的结核病治疗方法面临诸如耐药性,副作用和有限的新药开发等挑战.
- 新型抗结核药物对于应对当前疗法日益无效的抗结核药物至关重要.
研究的目的:
- 审查和选植物性天然化合物的抗结核活性.
- 为了突出库尔库作为一个有前途的候选人,由于其多目标作用和治疗性质.
- 探索天然产品在开发新的抗结核药物方面的潜力.
主要方法:
- 对具有抗结核活性的天然化合物的文献综述.
- 专注于植物性化合物,特别是黄素.
- 分析黄素的作用机制,抗炎和免疫调节作用.
主要成果:
- 自然资源为发现新型结核病治疗提供了可行的途径.
- 植物衍生化合物为药物开发提供了有价值的结构框架.
- 黄素作为抗结核剂具有显著的潜力.
结论:
- 迫切需要新的抗结核药物来克服耐药性并改善治疗结果.
- 自然产品,特别是黄素,是开发下一代结核病疗法的有希望的来源.
- 对黄素的疗效和安全性进行进一步的研究是必要的,因为它对结核病的临床应用是有必要的.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I
221
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
221
Pulmonary Tuberculosis II
213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis III
312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
312
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K


